Hepatic arterial infusion of autologous CD34+ cells for hepatitis C virus-related decompensated cirrhosis: A multicenter, open-label, exploratory randomized controlled trial
Author:
Funder
Japan Agency for Medical Research and Development
Publisher
Elsevier BV
Reference34 articles.
1. Transition in the etiology of liver cirrhosis in Japan: a nationwide survey;Enomoto;J Gastroenterol,2020
2. Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity;Krassenburg;J Hepatol,2021
3. Efficacy and safety of sofosbuvir-velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial;Takehara;J Gastroenterol,2019
4. Time-course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis;Atsukawa;Hepatol Res,2022
5. Hepatocellular carcinoma development in sustained viral responders to interferon therapy in patients with chronic hepatitis C;Enokimura;Anticancer Res,2003
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. O uso da transfusão sanguínea autóloga na cirurgia do aparelho digestivo: uma revisão de literatura;Journal Archives of Health;2024-07-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3